Should Asymptomatic Patients Be Tested for Chlamydia Trachomatis in General Practice?

Overview

Journal Br J Gen Pract

Specialty Public Health

Date 1990 Apr 1

PMID 2115349

Citations 12

Authors

H Buhaug

F E Skjeldestad

L E Halvorsen

A Dalen

Affiliations

Soon will be listed here.

Abstract

Routine testing for Chlamydia trachomatis during gynaecological examinations has been suggested as a preventive measure against pelvic inflammatory disease and other health risks associated with chlamydial genital infections. This study examined the cost and effectiveness of routine testing for C trachomatis in general practice. An epidemiological model was used to predict how routine testing and treatment of positive cases would affect the future number of cases of pelvic inflammatory disease, infertility and ectopic pregnancy in a general practice population. The cost of routine test and treatment, and savings resulting from prevented future morbidity, were also estimated. For the population under study, a routine test for chlamydial infections in asymptomatic 18-24 year old women during gynaecological examinations was found to be cost effective but this was not the case for older women. At least two years should elapse between repeated tests.

Citing Articles

The Use of Mathematical Models of Chlamydia Transmission to Address Public Health Policy Questions: A Systematic Review.

Ronn M, Wolf E, Chesson H, Menzies N, Galer K, Gorwitz R Sex Transm Dis. 2017; 44(5):278-283.

PMID: 28407643 PMC: 6727649. DOI: 10.1097/OLQ.0000000000000598.

Optimizing strategies for population-based chlamydia infection screening among young women: an age-structured system dynamics approach.

Teng Y, Kong N, Tu W BMC Public Health. 2015; 15:639.

PMID: 26162374 PMC: 4498533. DOI: 10.1186/s12889-015-1975-z.

Estimating age-dependent per-encounter chlamydia trachomatis acquisition risk via a Markov-based state-transition model.

Teng Y, Kong N, Tu W J Clin Bioinforma. 2014; 4:7.

PMID: 24872872 PMC: 4022339. DOI: 10.1186/2043-9113-4-7.

How robust are the natural history parameters used in chlamydia transmission dynamic models? A systematic review.

Davies B, Anderson S, Turner K, Ward H Theor Biol Med Model. 2014; 11:8.

PMID: 24476335 PMC: 3922653. DOI: 10.1186/1742-4682-11-8.

One to one interventions to reduce sexually transmitted infections and under the age of 18 conceptions: a systematic review of the economic evaluations.

Barham L, Lewis D, Latimer N Sex Transm Infect. 2007; 83(6):441-6.

PMID: 17626115 PMC: 2598700. DOI: 10.1136/sti.2007.025361.

References

Schachter J, Stoner E, Moncada J . Screening for chlamydial infections in women attending family planning clinics. West J Med. 1983; 138(3):375-9. PMC: 1021473. View

GJONNAESS H, Dalaker K, Anestad G, Mardh P, Kvile G, Bergan T . Pelvic inflammatory disease: etiologic studies with emphasis on chlamydial infection. Obstet Gynecol. 1982; 59(5):550-5. View

THOMPSON S, Washington A . Epidemiology of sexually transmitted Chlamydia trachomatis infections. Epidemiol Rev. 1983; 5:96-123. DOI: 10.1093/oxfordjournals.epirev.a036266. View

Fox H . Chlamydial cervicitis: a research study from general practice. J R Coll Gen Pract. 1983; 33(256):721-4. PMC: 1972963. View

Handsfield H, Jasman L, Roberts P, Hanson V, Kothenbeutel R, Stamm W . Criteria for selective screening for Chlamydia trachomatis infection in women attending family planning clinics. JAMA. 1986; 255(13):1730-4. View

Washington A, Arno P, Brooks M . The economic cost of pelvic inflammatory disease. JAMA. 1986; 255(13):1735-8. View

Rahm V, Gnarpe H, Rosen G . [Chlamydia commonly present in the teenage girls consulting the family planning clinics]. Lakartidningen. 1986; 83(8):615-6. View

Phillips R, Aronson M, Taylor W, Safran C . Should tests for Chlamydia trachomatis cervical infection be done during routine gynecologic visits? An analysis of the costs of alternative strategies. Ann Intern Med. 1987; 107(2):188-94. DOI: 10.7326/0003-4819-107-2-188. View

Skjeldestad F, Dalen A, Buhaug H, Bakketeig L . [Chlamydia trachomatis. Screening of pregnant women]. Tidsskr Nor Laegeforen. 1987; 107(25):2129-31. View

10.

Nettleman M, Jones R . Cost-effectiveness of screening women at moderate risk for genital infections caused by Chlamydia trachomatis. JAMA. 1988; 260(2):207-13. View

11.

Halvorsen L, Skjeldestad F, Mecsei R, Dalen A . [Chlamydia trachomatis in cervix uteri specimens among patients in general practice]. Tidsskr Nor Laegeforen. 1988; 108(30):2706-8. View

12.

Buhaug H, Skjeldestad F, Backe B, Dalen A . Cost effectiveness of testing for chlamydial infections in asymptomatic women. Med Care. 1989; 27(8):833-41. DOI: 10.1097/00005650-198908000-00007. View

13.

Avonts D, Sercu M, Heyerick P, Vandermeeren I, Piot P . Sexually transmitted diseases and Chlamydia trachomatis in women consulting for contraception. J R Coll Gen Pract. 1989; 39(327):418-20. PMC: 1712114. View

14.

Svensson L, Mardh P, Westrom L . Infertility after acute salpingitis with special reference to Chlamydia trachomatis. Fertil Steril. 1983; 40(3):322-9. DOI: 10.1016/s0015-0282(16)47294-8. View

15.

Mardh P, Ripa T, Svensson L, Westrom L . Chlamydia trachomatis infection in patients with acute salpingitis. N Engl J Med. 1977; 296(24):1377-9. DOI: 10.1056/NEJM197706162962403. View

16.

Westrom L . Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol. 1980; 138(7 Pt 2):880-92. DOI: 10.1016/0002-9378(80)91077-7. View

17.

Bowie W, Manzon L, Fawcett A, Jones H . Efficacy of treatment regimens for lower urogenital Chlamydia trachomatis infection in women. Am J Obstet Gynecol. 1982; 142(2):125-9. DOI: 10.1016/s0002-9378(16)32325-0. View